ImmunoGen reports financial results for 2016 third quarter
ImmunoGen reported a net loss of $44.7 million in the 2016 third quarter versus a net loss of $33.7 million for the same 2015 quarter. Revenues for the 2016 third quarter were $7.7 million versus $14.9 million for the same 2015 quarter. October 28, 2016